Damora Therapeutics, Inc. (DMRA) at a glance

Damora Therapeutics, Inc. (DMRA) is a small-cap Healthcare company. It trades at $29.01, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Momentum (68/100) and its weakest is Income (40/100). It carries above-market volatility, so expect larger swings.

Price

$29.01

Market cap

$1.28B

P/E ratio

n/a

Dividend yield

None

Beta

1.48

52-week range

$2.45 to $38.33